artemisinin and u 0126
artemisinin has been researched along with u 0126 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Cao, J; Fan, Y; Gao, L; Wang, C; Wang, Y; Xie, Y; Xu, Z; Yin, Z | 1 |
Other Studies
2 other study(ies) available for artemisinin and u 0126
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Artemisinin inhibits monocyte adhesion to HUVECs through the NF-κB and MAPK pathways in vitro.
Topics: Anti-Inflammatory Agents; Artemisinins; Butadienes; Cell Adhesion; Cell Line; Coculture Techniques; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Intercellular Adhesion Molecule-1; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monocytes; NF-kappa B; Nitriles; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Signal Transduction; Sulfones; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2016 |